FOR IMMEDIATE RELEASE: June 7, 2013
Contact: Meico Whitlock, 202-434-8094, www.NASTAD.org
Congresswoman Barbara Lee
Washington, DC– The National Alliance of State and Territorial AIDS Directors (NASTAD) recognized Representative Barbara Lee (CA-13th District) with the Partnership Award at its 22nd Annual Meeting of state health department HIV and hepatitis program leaders last month. The meeting takes place every May in Washington, D.C. Barbara Lee is a long-standing member of the U.S. House of Representatives and has been a champion of HIV/AIDS on a variety of issues both domestic and global.
“Barbara has long been a champion of efforts to end HIV/AIDS and advance human rights here at home and abroad. Her achievements in Congress and in the HIV community are unquestionable,” noted NASTAD Executive Director Julie Scofield.
Over the years, Rep. Lee has:
- Been a key sponsor in establishing and supporting the Minority AIDS Initiative.
- Been an active member of the House Appropriations Committee, fighting for funding for both domestic and global HIV programs in her role on both the Labor-HHS and the State-Foreign Ops Subcommittees. Continue reading
By Dawn Fukuda, Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair (Incoming)
Dawn Fukuda, Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair
For perhaps the first time in history, the end of HIV/AIDS and hepatitis is within our reach. Recent notable achievements provide promise for success, among them the release of the National HIV/AIDS Strategy (NHAS) and the Viral Hepatitis Action Plan (VHAP) and the passage of the Affordable Care Act (ACA). Collectively, these achievements have catalyzed the beginning of a radical transformation in our healthcare systems for communities impacted by HIV and hepatitis. In particular, the ACA represents an opportunity for the country to expand access to HIV/AIDS and hepatitis prevention, medical care, and health promotion services in profound and impactful ways. The systems-level changes advanced in the legislation also require state health departments to reassess their role in the context of an evolving health care system and the other sources of financing that may become available to support what have historically been public health functions—this is particularly the case for HIV/AIDS and viral hepatitis prevention and care services. Continue reading
By Randy Mayer, Chief, Bureau of HIV, STD, and Hepatitis, Iowa Department of Public Health and NASTAD Chair (Outgoing)
Randy Mayer, Chief, Bureau of HIV, STD, and Hepatitis, Iowa Department of Public Health
As I began my tenure as NASTAD’s Chair in May 2012, state health department HIV and viral hepatitis programs were trying to understand and react to the impact of the funding redistributions brought about by the Centers for Disease Control and Preventions’ (CDC) HIV prevention funding opportunity announcement 12-1201. At the same time, we were just learning about the possibility of fiscal sequestration, set to begin in early 2013. NASTAD’s analysis pointed to the potential for an overall 8.2 percent cut to HIV/AIDS and viral hepatitis programs that would severely impact ADAP enrollment and critical prevention, surveillance and viral hepatitis programming. The cuts would be especially devastating at a time when ending HIV/AIDS and viral hepatitis is within our reach. The National HIV/AIDS Strategy (NHAS) and the Department of Health and Human Services’ Viral Hepatitis Action Plan provide roadmaps for reducing new infections and increasing access to care, but these cuts mean we may never be able to realize these goals. Continue reading